Brown Advisory’s Ginkgo Bioworks DNA Stock Holding History

Brown Advisory's DNA Position: Q2 2026 in Review

Brown Advisory opened a new position in Ginkgo Bioworks (DNA) in Q2 2026: 59,206 shares worth $587K. The stake represents ﹤0.01% of the portfolio and ranks #1091 among its holdings. This is a return to the name: Brown Advisory previously reported a position in DNA as recently as Q2 2024.

Brown Advisory first reported a position in DNA in Q1 2022 and has held it in 11 quarters since. 184 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

• Brown Advisory held 59,206 shares of Ginkgo Bioworks worth $587K as of Q2 2026.
• Ginkgo Bioworks was a new Brown Advisory position in Q2 2026.
• Ginkgo Bioworks made up ﹤0.01% of Brown Advisory's portfolio in Q2 2026, its #1091 holding.
• Brown Advisory first reported a position in Ginkgo Bioworks in Q1 2022 and has held it in 11 quarters since.
• 184 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Brown Advisory's 13F filing for Q2 2026, filed 14 Aug 2026.